Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed Nov 18, 2022
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Purchase
Common Stock
2022-11-16$7.10/sh+150$1,065→ 1,245,215 total - Purchase
Common Stock
2022-11-17$7.20/sh+150$1,080→ 1,245,365 total
Footnotes (1)
- [F1]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.